ACHE and Alzheimer disease: Thus, AChE inhibitors, currently approved drugs to treat AD, have been shown to reduce cognitive manifestations, without delaying or halting the progression of the disease16.Thus, we evaluated the QTC-4-MeOBnE binding affinity with AChE on CAS and on PAS.